Company Cash on Hand: purple-biotech.com (PPBT)

PPBT (Purple Biotech Corp) - company brandmark

The cash balance demonstrates the liquid reserves of Purple Biotech (PPBT), with the value stabilizing at 0.01. Purple Biotech (PPBT) develops innovative molecules to combat metastases and tumor resistance. Drug development relies on global partnerships with institutions, which enhances M&A prospects. The continuity of research is guaranteed by distributing contract centers across safe-haven regions.

PPBT - Purple Biotech Ltd Company Cash Funds over the range 07/04/2022 - 11/21/2026

Summary analytical data breakdowns for Purple Biotech Corp (PPBT)

- company stock exchange capitalization indicators:
Summary company analysis:Purple Biotech Ltd
Signature product of Purple Biotech Ltd

Investors are assessing the financial stability of Purple Biotech (PPBT) through liquidity analysis. This metric measures the volume of cash and equivalents available for the immediate coverage of operating expenses. The cash flow dynamics of Purple Biotech demonstrate the business's ability to fund clinical trials without external borrowing. For a biotech startup lacking active partnerships, this reserve serves as the sole guarantee of survival. A stable cash balance confirms the viability of the current molecule development strategy.

Competitors of Purple Biotech (PPBT)

Company Cash Volume ONC|HALO - Company Cash Reserve|Revolution Medicines - Company Cash on Hand|Company Cash Volume Ascentage Pharma AAPG|CGON - Company Cash Funds|Company Total Cash Volume URGN|BCAX: Company Cash Volume|PSNL - Company Liquid Assets|ERAS (Erasca Inc) - Company Cash Volume|Company Cash Reserve Delcath Systems Inc DCTH|Company Cash Funds YmAbs (YMAB)|Company Liquid Assets Aura Bio|Company Cash Volume CADL (Candel Therapeutics Inc.)|accuray.com (ARAY) - Company Cash Reserve|SELLAS Life Sciences Group - Company Cash Volume|ACTU - Company Cash Volume|CTOR: Company Cash Volume|Company Cash Reserve TuHURA (HURA)|TARA (Protara Therapeutics Inc) - Company Cash Volume|Fate Therapeutics, Inc. (FATE) - Company Liquid Assets|Company Cash on Hand WHWK (Aadi Bioscience, Inc.)|Company Liquid Assets TScan Therapeutics, Inc.|Company Cash Volume CSBR (Champions Oncology Corp)|Company Total Cash Amount XBIT (XBiotech USA)|CVM - Company Cash Funds|Company Cash Balance OSTX (ostherapies.com)|Radiopharm Theranostics Ltd (RADX) - Company Cash Funds|ARTV: Company Total Cash Amount|ANL (adlainortye.com) - Company Cash Volume|VERU: Company Cash Balance|Company Cash on Hand TPST (Tempest Tx)|Company Cash on Hand Xilio XLO|Company Cash Volume RENB (Renovaro)|Company Cash Volume Mural Bio MURA|Kairos Pharma Ltd - Company Cash Volume|OnKure Therapeutics (OKUR) - Company Cash on Hand|GDTC: Company Cash Volume|Curis Inc. - Company Cash Balance|Company Cash Funds apollomicsinc.com|THAR: Company Cash Balance|Company Cash Funds Advanced Biomed Corp (ADVB)|GNPX (Genprex, Inc) - Company Cash Balance|Company Cash Volume CLDI (Calidi Biotherapeutics)|sunshinebiopharma.com (SBFM) - Company Cash Reserve|Xenetic Bio - Company Cash Volume|SLRX (Salarius Pharmaceuticals, Inc.) - Company Cash and Cash Equivalents|AONC: Company Cash Volume|Company Cash Reserve BeOne Medicines (BGNE)|Company Cash Funds Checkpoint Therapeutics, Inc.|Company Cash on Hand Elevation Oncology (ELEV)|Company Cash Funds iCAD Corp (ICAD)|Company Cash on Hand Ikena IKNA|Company Cash Volume NTBL (notablelabs.com)|VIRX - Company Cash on Hand|MOR: Company Cash on Hand|NAYA - Company Cash Volume|Ascentage Pharma (AAPGV) - Company Cash Funds